Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue.

Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, Cho I, Ullman T, Mayer L, Loke P.

Mucosal Immunol. 2014 Jan;7(1):124-33. doi: 10.1038/mi.2013.31. Epub 2013 May 22.

2.

Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.

Globig AM, Hennecke N, Martin B, Seidl M, Ruf G, Hasselblatt P, Thimme R, Bengsch B.

Inflamm Bowel Dis. 2014 Dec;20(12):2321-9. doi: 10.1097/MIB.0000000000000210.

PMID:
25248005
3.

TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.

Olsen T, Rismo R, Cui G, Goll R, Christiansen I, Florholmen J.

Cytokine. 2011 Dec;56(3):633-40. doi: 10.1016/j.cyto.2011.08.036. Epub 2011 Sep 25.

PMID:
21945121
4.
6.

Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.

Melgar S, Yeung MM, Bas A, Forsberg G, Suhr O, Oberg A, Hammarstrom S, Danielsson A, Hammarstrom ML.

Clin Exp Immunol. 2003 Oct;134(1):127-37.

7.

Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.

Liu Z, Yang L, Cui Y, Wang X, Guo C, Huang Z, Kan Q, Liu Z, Liu Y.

Inflamm Bowel Dis. 2009 Aug;15(8):1133-44. doi: 10.1002/ibd.20923.

PMID:
19322899
8.

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.

Hovhannisyan Z, Treatman J, Littman DR, Mayer L.

Gastroenterology. 2011 Mar;140(3):957-65. doi: 10.1053/j.gastro.2010.12.002. Epub 2010 Dec 11.

9.

Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S.

J Clin Immunol. 2010 Jan;30(1):80-9. doi: 10.1007/s10875-009-9345-1.

PMID:
19936899
10.

Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.

Liu C, Xia X, Wu W, Wu R, Tang M, Chen T, Xu F, Cong Y, Xu X, Liu Z.

Clin Exp Immunol. 2013 Jul;173(1):102-11. doi: 10.1111/cei.12084.

11.

IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness.

Holmkvist P, Pool L, Hägerbrand K, Agace WW, Rivollier A.

Eur J Immunol. 2016 Jun;46(6):1371-82. doi: 10.1002/eji.201545957. Epub 2016 May 6.

12.

Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.

Berndt U, Bartsch S, Philipsen L, Danese S, Wiedenmann B, Dignass AU, Hämmerle M, Sturm A.

J Immunol. 2007 Jul 1;179(1):295-304.

13.

Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.

Sarra M, Monteleone I, Stolfi C, Fantini MC, Sileri P, Sica G, Tersigni R, Macdonald TT, Pallone F, Monteleone G.

Inflamm Bowel Dis. 2010 Aug;16(8):1332-9. doi: 10.1002/ibd.21238.

PMID:
20186935
14.

Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.

Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P, Chatelain D, Barre A, Nguyen-Khac E, Lantz O, Dupas JL, Treiner E.

Clin Exp Immunol. 2014 May;176(2):266-74. doi: 10.1111/cei.12277.

15.

IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.

Su J, Chen T, Ji XY, Liu C, Yadav PK, Wu R, Yang P, Liu Z.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):720-8. doi: 10.1097/MIB.0b013e3182802a76.

PMID:
23429464
16.

TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.

Ślebioda TJ, Bojarska-Junak A, Stanisławowski M, Cyman M, Wierzbicki PM, Roliński J, Celiński K, Kmieć Z.

Scand J Immunol. 2015 Oct;82(4):352-60. doi: 10.1111/sji.12324.

17.

Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.

Meenan J, Spaans J, Grool TA, Pals ST, Tytgat GN, van Deventer SJ.

Gut. 1997 Feb;40(2):241-6.

18.

Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.

Ogino T, Nishimura J, Barman S, Kayama H, Uematsu S, Okuzaki D, Osawa H, Haraguchi N, Uemura M, Hata T, Takemasa I, Mizushima T, Yamamoto H, Takeda K, Doki Y, Mori M.

Gastroenterology. 2013 Dec;145(6):1380-91.e1. doi: 10.1053/j.gastro.2013.08.049. Epub 2013 Aug 29.

PMID:
23993972
19.

Absence of a role for interleukin-13 in inflammatory bowel disease.

Biancheri P, Di Sabatino A, Ammoscato F, Facciotti F, Caprioli F, Curciarello R, Hoque SS, Ghanbari A, Joe-Njoku I, Giuffrida P, Rovedatti L, Geginat J, Corazza GR, MacDonald TT.

Eur J Immunol. 2014 Feb;44(2):370-85. doi: 10.1002/eji.201343524.

20.

miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.

He C, Shi Y, Wu R, Sun M, Fang L, Wu W, Liu C, Tang M, Li Z, Wang P, Cong Y, Liu Z.

Gut. 2016 Dec;65(12):1938-1950. doi: 10.1136/gutjnl-2015-309389. Epub 2015 Sep 3.

PMID:
26338824

Supplemental Content

Support Center